Marlene P. Freeman, MD
Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts
ASCP Corner
Neuroactive Steroids for Depression: Potential Implications for PMDD
June 8, 2021
Recent promising data indicate that neuroactive steroids could have a role in treating depression. This article discusses the mechanisms behind potential beneficial effects in premenstrual dysphoric disorder as well.
Original Research
Adjunctive Pimavanserin and Sleep/Wakefulness in MDD
December 1, 2020
Adjunctive pimavanserin can reduce depressive symptoms and improve function in patients with major depression and inadequate antidepressant response. This analysis evaluated the effects of adjunctive pimavanserin on sleep/wakefulness disturbances.